Bi-specific MHC Heterodimers for Characterization of Cross-reactive T Cells*

  1. Lawrence J. Stern,1
  1. From the Department of Pathology,
  2. §Division of Diabetes, and
  3. Department of Biochemistry & Molecular Pharmacology, University of Massachusetts Medical School, Worcester, Massachusetts 01655
  1. 1 To whom correspondence should be addressed: S2-127, 55 Lake Ave. North, Worcester, MA 01655. Fax: 508-856-0019; E-mail: lawrence.stern{at}umassmed.edu.

Abstract

T cell cross-reactivity describes the phenomenon whereby a single T cell can recognize two or more different peptide antigens presented in complex with MHC proteins. Cross-reactive T cells have previously been characterized at the population level by cytokine secretion and MHC tetramer staining assays, but single-cell analysis is difficult or impossible using these methods. In this study, we describe development of a novel peptide-MHC heterodimer specific for cross-reactive T cells. MHC-peptide monomers were independently conjugated to hydrazide or aldehyde-containing cross-linkers using thiol-maleimide coupling at cysteine residues introduced into recombinant MHC heavy chain proteins. Hydrazone formation provided bi-specific MHC heterodimers carrying two different peptides. Using this approach we prepared heterodimers of the murine class I MHC protein H-2Kb carrying peptides from lymphocytic choriomeningitis virus and vaccinia virus, and used these to identify cross-reactive CD8+ T cells recognizing both lymphocytic choriomeningitis virus and vaccinia virus antigens. A similar strategy could be used to develop reagents to analyze cross-reactive T cell responses in humans.

Footnotes

  • * This work was supported, in whole or in part, by National Institutes of Health Grants U19-AI057319 (to L. J. S.) and AI081675 (to R. M. W.) and University of Massachusetts Medical School FACS and Proteomics Core resources supported by Diabetes Endocrinology Research Center Grant DK32520.

  • Graphic The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. S1–S3.

  • Received May 4, 2010.
  • Revision received July 25, 2010.
Table of Contents

Submit your work to JBC.

You'll be in good company.